Nachrichten zur Johnson & Johnson Aktie

Is Johnson & Johnson a Good Dividend Stock to Buy Now? @themotleyfool #stocks $JNJ

The healthcare conglomerate has been raising its dividend payout since Kennedy was president, but there have been some recent changes.…

[Latest] Global Medical Implant Market Size/Share Worth USD 203.6 Billion by 2032 at a 6.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

A Johnson & Johnson Worker Alleges Company Overpaid for Drugs

Johnson & Johnson was sued by an employee who says that the company health plan wasted workers’ money by paying…

Johnson Outdoors Inc. (JOUT) Q1 2024 Earnings Call Transcript

…

Johnson Outdoors Reports Fiscal First Quarter Results

RACINE, Wis., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq:JOUT), a leading global innovator of outdoor…

Man to ring New York Stock Exchange bell for Black History Month

“It’ll be an honor to stand with my colleagues for the opening of Black History Month,” Johnson said.…

Heres What to Expect From Johnson Outdoors (JOUT) Q1 Earnings

Johnson Outdoors (JOUT) Q1 performance to reflect elevated retail inventories and higher marketing and professional services costs.…

Johnson Controls (JCI) Q1 Earnings Beat, Revenues Rise Y/Y

Johnson Controls (JCI) fiscal first-quarter results benefit from strength in the HVAC & controls businesses.…

Johnson & Johnson: Medtech-Momentum & GLP-Risiko am Horizont - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Global Hot & Cold Systems Market Size To Worth USD 30.9 Billion By 2032 | CAGR of 3.5%

The Global Hot & Cold Systems Market Size was valued at USD 21.8 Billion in 2022 and the Worldwide Hot…

Johnson & Johnson: Positioned To Receive Benefits Of Heavy R&D Investments

…

Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson

These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?…

Merck, Johnson & Johnson CEOs agree to testify in Senate hearing on high drug prices

The CEOs of Merck, Johnson & Johnson and Bristol Myers Squibb will testify at the hearing on drug prices, Sen.…

Johnson Controls pops on report of HVAC asset sale

…

Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon

Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.…

Better Dividend Stock to Buy Now: Johnson & Johnson vs. Verizon @themotleyfool #stocks $VZ $JNJ

Both recently reported results from the fourth quarter of 2023 and their performances could hardly look more different.…

Auslandsaktien: „Zweite und dritte Reihe könnte nachziehen“

Die US-Berichtssaison ist in vollem Gange. Für die großen US-Tech-Werte, die „Magnificant Seven“, gibt es eine Menge Vorschusslorbeeren. Unternehmen aus…

What to Note Ahead of Johnson Controls (JCI) Q1 Earnings

Johnson Controls (JCI) first-quarter fiscal 2024 results are likely to reflect a slowdown in the residential market and the challenging…

3M mit schwachem Ausblick - Auch GE-Ausblick enttäuscht - United Airlines zeigt sich optimistisch

Wien (www.aktiencheck.de) - Johnson & Johnson (ISIN: US4781601046, WKN: 853260, Ticker-Symbol: JNJ, NYSE-Symbol: JNJ) (-1,6%) konnte im Vorjahr mit einem…

Proctor & Gambles Wachstum verlangsamt sich - Johnson & Johnson profitiert von Abspaltung der Konsumgütersparte

Konsumgüterriese Proctor&Gamble wächst weniger stark als erwartet. Johnson & Jonson schließt Geschäftsjahr 2023 stärker als prognostiziert.Im letzten Quartal des Jahres…

J&J’s Spravato success confirms commercial viability of psychedelics for mental health

The commercial success of Johnson & Johnson (NYSE:JNJ)s esketamine nasal spray Spravato for use in treatment-resistant depression and major depressive...…

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million

The settlement does not resolve the tens of thousands of lawsuits alleging that J&Js talc-based products caused cancer.…

Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript

JNJ earnings call for the period ending December 31, 2023.…

Johnson & Johnson 2023 Q4 - Results - Earnings Call Presentation

…

Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript

…

Drug Pipeline Is Well Positioned for 2024, Says J&J CFO

Joseph Wolk, Johnson & Johnson Chief Financial Officer, says the drug pipeline is well positioned for this year. He also…

Johnson & Johnson mit guten Zahlen - Prognose steht

In den USA nimmt die Berichtssaison allmählich an Fahrt auf. Am Dienstag hat auch Johnson & Johnson frische Zahlen zum…

Johnson Controls: 2.7% Yield And A Realistic Path To 15% Annual Returns

…

Johnson & Johnson mit guten Zahlen – Prognose steht

In den USA nimmt die Berichtssaison allmählich an Fahrt auf. Am Dienstag hat auch Johnson & Johnson frische Zahlen zum…

Johnson & Johnson verdient 2023 mehr - Schlussquartal unerwartet stark

NEW BRUNSWICK (dpa-AFX) - Der Pharma- und Medizintechnik-Konzern Johnson & Johnson (J&J) hat 2023 von…

Johnson & Johnson undershoots full-year earnings guidance

New Jersey-based pharmaceutical giant Johnson & Johnson (NYSE:JNJ) hit top-line expectations in today’s annual earnings call, but slightly undershot with...…

Dwayne ‘The Rock’ Johnson joins board of WWE owner

Dwayne ‘The Rock’ Johnson has been appointed to the board of TKO, the company which owns both the WWE and…

Johnson & Johnson: MedTech als Wachstumsmotor - Aktienanalyse

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Johnson & Johnson holds 2024 profit forecast steady after solid Q4 earnings

Johnson & Johnson says its on track to meet its 2025 target of $57 billion in pharmaceutical sales.…

Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4

…

Johnson & Johnson Q4 earnings beat estimates amid strength in medtech

…

Johnson & Johnson tops revenue estimates, reiterates forecast By Investing.com

Johnson & Johnson tops revenue estimates, reiterates forecast…

Johnson & Johnson narrowly tops quarterly estimates as pharmaceutical, medtech sales jump

The results come six months after J&J completed its spinoff of consumer health unit Kenvue, the companys biggest shake-up in…

Surgical Dressing Market Valuation to Reach US$1.9 Billion by 2030, Driven by 6.1% CAGR | Persistence Market Research

Discover the dynamic world of the surgical dressing market with a comprehensive market overview. Explore key statistics, technology trends, market…

Johnson & Johnson Is a Changed Company. What to Expect From Earnings.

…

Global Hand Wash Market Size To Exceed USD 7.23 Billion By 2032 | CAGR of 7.1%

The Global Hand Wash Market Size was valued at USD 3.62 Billion in 2022 and the Worldwide Hand Wash Market…

New ADHD drugs could pay off for pharmaceutical companies (NASDAQ:AXSM)

Pharmaceutical companies would be wise to pay attention to developing new treatments for ADHD as there is a demand for…

Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more

…

Wochenausblick - Die Quartalssaison steht in den Startlöchern.

WerbungZum Start in die neue Börsenwoche informieren wir jeden Sonntag über Wirtschaftsdaten, Quartalszahlen und mehr. Neben den Quartalszahlen von Netflix,…

Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa

…

Window Film Market to reach $96.9 Bn by 2032, Says Global Market Insights Inc.

Major window film market participants include Eastman Chemical Company (LLumar), 3M Company, Saint-Gobain Performance Plastics (Solar Gard), Avery Dennison, Madico,…

Top 5 Life Science ETFs

Taking a position in a life science exchange-traded fund (ETF) provides exposure to a basket of stocks focused on the…

Johnson & Johnson likely to post dip in 4Q earnings

Johnson & Johnson (NYSE:JNJ) raised its full-year guidance after a strong third quarter which saw earnings beat expectations and its…

Johnson & Johnson: Is The Dividend Still Safe After The Kenvue Split-Off?

…

Johnson Controls names new finance chief

…